Stoke Therapeutics Reports Full Year 2020 Financial Results and Provides Business Updates
– First patient dosed in the multiple ascending dose portion of Phase 1/2a MONARCH study of STK-001 in Dravet syndrome...
Results
Inari Medical Reports Fourth Quarter and Full Year 2020 Financial Results
IRVINE, Calif., March 09, 2021 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a commercial-stage medical device company focused...
Oak Street Health Reports Fourth Quarter 2020 Financial Results | Business & Finance
CHICAGO--(BUSINESS WIRE)--Mar 9, 2021--Oak Street Health, Inc. (NYSE: OSH) (the “Company”), a network of value-based, primary care centers for adults...
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter 2020 Financial Results
PCDH19 related epilepsy (PCDH19-RE) Phase 2 Violet Study Proof-of-Concept Trial (n=21) shows a median 61.5% reduction in seizure frequency for...
COMPASS Pathways plc announces financial results and business highlights for fourth quarter and year-end 2020
Highlights include continued progress with phase IIb psilocybin therapy clinical trial, launch of first Centre of Excellence, and expansion of...
ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2020
ERYTECH Provides Business Update and Reports Financial Results for the Full Year 2020Conference call and webcast on Tuesday, March 9,...
NextCure Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
BELTSVILLE, Md., March 04, 2021 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and...
Imara Reports Full Year 2020 Financial Results and Business Highlights
Significant progress advancing IMR-687 as an oral, once-a-day potentially disease modifying treatment for sickle cell disease and beta-thalassemiaReports new Phase...
Aeromexico Studies February 2021 Website traffic Results
BloombergTreasury Small Sellers Experience Increasing Fees to Borrow 10-Year Notes(Bloomberg) -- The charge of borrowing U.S. Treasury 10-year notes continues...
Acorda Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results
Sale of Manufacturing Operations to Catalent with net proceeds of ~$74 millionAnnual operating expenses cut by ~$40 million via sale,...
ObsEva Announces Year End 2020 Financial Results and Business Update
-Yselty® for uterine fibroids: US New Drug Application filing planned in Q2:21; European marketing approval anticipated in Q4:21--Yselty® for endometriosis:...
Eloxx Prescription drugs to Report Fourth Quarter and Total Year 2020 Money Final results and Offer Enterprise Update on March 11, 2021
Organization administration to host a webcast and conference phone to present a small business update and overview financial success at...
Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results
Enrollment ongoing in 3 Cellectis-sponsored Phase 1 dose-escalation trials BALLI-01 in r/r B-ALL patients, AMELI-01 in r/r AML patients and...
Kadmon Provides Business Update and Reports Fourth Quarter 2020 Financial Results
NEW YORK, NY / ACCESSWIRE / March 4, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today provided a business update and...
VYNE Therapeutics Reports Year-End 2020 Financial Results and Provides Business Update
Conference call and live webcast to discuss financial results and new FMX114 program in atopic dermatitis today, Thursday, March 4,...
argenx Reports Full Year 2020 Financial Results and Provides Fourth Quarter Business Update
- Biologics License Application (BLA) for IV efgartigimod accepted for review by U.S. Food and Drug Administration (FDA) for generalized...
Fulcrum Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results
– Company on track to present data from Phase 2b ReDUX4 trial with losmapimod in facioscapulohumeral muscular dystrophy (FSHD) in...
Ciena Reports Fiscal First Quarter 2021 Financial Results | Business & Finance
HANOVER, Md.--(BUSINESS WIRE)--Mar 4, 2021--Ciena® Corporation (NYSE: CIEN), a networking systems, services and software company, today announced unaudited financial results...
